• Early Detection Saves Lives

    Many lives are lost to cancer owing to the late stage of detection.
    At Sascan we utilize a multispectral imaging technology platform for
    multimodal screening and early detection of potentially malignant lesions.

  • Early Detection Saves Lives

    Many lives are lost to cancer owing to the late stage of detection.
    At Sascan we utilize a multispectral imaging technology platform for
    multimodal screening and early detection of potentially malignant lesions.

  • Early Detection Saves Lives

    Many lives are lost to cancer owing to the late stage of detection.
    At Sascan we utilize a multispectral imaging technology platform for
    multimodal screening and early detection of potentially malignant lesions.

  • Early Detection Saves Lives

    Many lives are lost to cancer owing to the late stage of detection.
    At Sascan we utilize a multispectral imaging technology platform for
    multimodal screening and early detection of potentially malignant lesions.

  • Early Detection Saves Lives

    Many lives are lost to cancer owing to the late stage of detection.
    At Sascan we utilize a multispectral imaging technology platform for
    multimodal screening and early detection of potentially malignant lesions.



Technology

Our multispectral imaging camera is configured to detect changes in diffuse reflectance, absorption and fluorescence of tissues associated with biochemical and morphological changes during early stages of cancer development.


Edge

We use a high resolution monochrome camera for accurate and real-time mapping of oxygenated hemoglobin absorption in tissue. This helps to locate the most malignant site for biopsy, thereby avoiding under diagnosis and repeated biopsies.


Applications

Our patented multimodal technology can detect most forms of squamous cell carcinoma, which constitute one-third of all cancers. The device can be adapted for endoscopy and tissue margin delineation during cancer surgery.


Impact

Our technology is suited for opportunistic screening of potentially malignant tissues of the oral cavity and cervix at higher accuracy and lower per-patient cost. This will encourage large scale adoption and save millions of lives every year.

Why Cloud Computing?

Screening and early detection of precancerous lesions using white light is subjective, and ensuing biopsies are painful and time consuming, with low diagnostic accuracy, high costs and long wait  period. Our mission is to make cancer screening so accurate, painless and affordable that anyone can walk into a clinic for checkup and get the results in less than 5 minutes.

In order to achieve this, we use proprietary software to capture multispectral images of tissue fluorescence and diffuse reflectance on illumination with specific wavelengths of light matching the absorption of protoporphyrin IX and oxygenated hemoglobin in tissue.  The captured monochrome images are processed to quantitatively assess the extent and nature of tissue abnormality in real time with the help of a cloud based machine learning algorithm developed by correlation of image data with histopathological results of biopsy.